Sign in Subscribe
Medical centers

Reliability of Cerebrospinal Fluid Cytology in Diagnosing Solid Malignant CSF Metastasis

Strategic Insights

— 1 min read

Researchers at the University of Pittsburgh Medical Center have conducted a 10-year study to evaluate the reliability of cerebrospinal fluid (CSF) cytology for detecting and subclassifying solid malignant CSF metastasis. The study aimed to identify the types of solid malignant CSF metastasis and assess the accuracy of CSF cytology in diagnosing these conditions. The research found that CSF cytology is a reliable method for diagnosing solid malignant CSF metastasis, with the most common tumor origins being breast, lung, and melanoma.

Key Takeaways:

  • The study analyzed a total of 286 specimens from 171 patients over a 10-year period (2014-2024).
  • Of the 286 specimens, 150 patients met the inclusion criteria, with 39 breast carcinoma, 26 lung adenocarcinoma, 15 melanoma, and other types of solid malignant CSF metastasis.
  • The study found that CSF cytology can provide a reliable and accurate method for diagnosing solid malignant CSF metastasis.
  • The most common tumor origins at the institution were breast, lung, and melanoma.
  • 30% of cases had limited cellularity and inability to perform ancillary testing, precluding further subclassification.
  • Rare tumors were detected, including metastatic bladder signet ring adenocarcinoma and metastatic nuclear protein in testis carcinoma.
  • The study's findings are consistent with existing literature, highlighting the importance of CSF cytology in diagnosing solid malignant CSF metastasis.

Statistics:

  • 286 specimens from 171 patients were analyzed over a 10-year period (2014-2024).
  • 150 patients met the inclusion criteria.
  • 39 breast carcinoma, 26 lung adenocarcinoma, 15 melanoma, and other types of solid malignant CSF metastasis were identified.
  • 30% of cases had limited cellularity and inability to perform ancillary testing.
  • 20% of cases were metastatic carcinomas NOS, and 10% were metastatic adenocarcinomas NOS.

Sources:

  • Cytopathologic diagnosis of cerebrospinal fluid metastasis from solid tumors: a 10-year institutional review, Journal of the American Society of Cytopathology, 2025.
  • Reports from University of Pittsburgh Medical Center Provide New Insights into Solid Cancer (Cytopathologic diagnosis of cerebrospinal fluid metastasis from solid tumors: a 10-year institutional review), Health & Medicine Week, September 19, 2025; p 4799.

Read more